Enanta Pharmaceuticals Inc.
02/20/2026 | Press release | Archived content
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 20, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
|
|||||||
Enanta Pharmaceuticals Inc. published this content on February 20, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 23, 2026 at 11:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]